SNN

Smith+Nephew signs exclusive distribution agreement to provide unique NAVBIT SPRINT™ solution in Australia

Retrieved on: 
Monday, April 8, 2024
Surgeon, Orthopedic surgery, Science, Partnership, Risk, International, Dislocation, SVP, Patient, Hospital, Registry, Senior, SPRINT, SNN, Elective surgery, THA

Compact, single-use, and simple-to-use technology offers surgeons a fast, reliable navigation solution for hip arthroplasty

Key Points: 
  • Compact, single-use, and simple-to-use technology offers surgeons a fast, reliable navigation solution for hip arthroplasty
    Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, announced an agreement with NAVBIT to exclusively distribute the NAVBIT SPRINT™ in Australia during the recent Australian Orthopedics Association COE Meeting in Sydney.
  • This exclusive distribution builds upon the agreement Smith+Nephew announced for Japan in April 2023.
  • Lynette Walter, NAVBIT’s CEO said, “We are absolutely delighted to expand our partnership with Smith+Nephew into the Australian market.
  • Today we have higher expectations around the accuracy and precision of our surgery,” said Professor Bill Walter, Orthopaedic Surgeon and Founder of NAVBIT.

Smith+Nephew’s PICO™ Single Use Negative Pressure Wound Therapy System provides better clinical outcomes versus standard of care according to UK National Institute for Health and Care Excellence (NICE)

Retrieved on: 
Thursday, April 4, 2024
RCT, Pressure, Diabetes, Risk, Globalization, Patient, Area studies, Kidney disease, PICO, Senior, Smoking, Christianity in Singapore, SNN, BMI, Pharmaceutical industry

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the review of medical technologies guidance from the UK National Institute for Health and Care Excellence (NICE) for its PICO Single Use Negative Pressure Wound Therapy System (sNPWT).

Key Points: 
  • Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the review of medical technologies guidance from the UK National Institute for Health and Care Excellence (NICE) for its PICO Single Use Negative Pressure Wound Therapy System (sNPWT).
  • NICE have reviewed ‘Medical Technology Guideline 43 PICO negative pressure wound dressings for closed surgical incisions’ which recognises that Smith+Nephew’s PICO sNPWT provides better clinical outcomes than standard dressings in patients at high risk of surgical site infections (SSIs), at similar overall cost.
  • The 24 clinical studies included a total of 7,790 patients with PICO sNPWT being used in 3,754.
  • NICE concluded that PICO sNPWT is associated with fewer SSIs and seromas compared with standard wound dressings.

Smith+Nephew introduces the RENASYS™ EDGE Negative Pressure Wound Therapy System – an exciting new option in home-based care for patients living with chronic wounds

Retrieved on: 
Monday, April 1, 2024
Veteran, Patient, Pain, Ulcer, Pressure, NPWT, SNN, Pharmaceutical industry

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, is pleased to announce the launch of its RENASYS EDGE Negative Pressure Wound Therapy (NPWT) System in the US as a patient-centric option for treating chronic wounds.

Key Points: 
  • Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, is pleased to announce the launch of its RENASYS EDGE Negative Pressure Wound Therapy (NPWT) System in the US as a patient-centric option for treating chronic wounds.
  • *3 The RENASYS EDGE System is designed for patients suffering from these wounds and living at home.
  • Smith+Nephew is also announcing two new national distribution partners for the RENASYS EDGE System - SunMED Medical Solutions and First Nation Group.
  • “When designing the RENASYS EDGE System we kept patients and their needs in the forefront of our minds.

Smith+Nephew teams up with UFC to be first-ever Preferred Sports Medicine Technology Partner

Retrieved on: 
Monday, March 25, 2024
Knee, Health, Regeneration, Sport, Shoulder, Hip, UFC Performance Institute, Partnership, Patient, Life, Research, Athlete, Surgeon, Octagon, SNN, Safety, Sports medicine, UFC, Smith & Nephew, Rehabilitation

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it has been named the Preferred Sports Medicine Technology Partner of UFC – the world’s premier mixed martial arts organization and one of the foremost global brands in all of sports.

Key Points: 
  • Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it has been named the Preferred Sports Medicine Technology Partner of UFC – the world’s premier mixed martial arts organization and one of the foremost global brands in all of sports.
  • “We’re thrilled to have Smith+Nephew join us for the first time as an Official UFC Partner,” said Robby Miller, Vice President, UFC Global Partnerships.
  • “Through hard work, significant investment, and groundbreaking innovations like the UFC Performance Institute, UFC has become the industry leader in athlete health and safety in combat sports.
  • We are proud to partner with UFC and share a common goal to get patients back in the game quickly, safely, and effectively,” said Scott Schaffner, President Sports Medicine, Smith+Nephew.

Special Needs Network Secures Over $1 Million in Grant Funding for Groundbreaking Mental Health Initiative

Retrieved on: 
Tuesday, March 12, 2024
BIPOC, Depression, California Department, Disability, Latinx, Grammatical mood, Autism spectrum, Disability studies, African Americans, Anxiety, Toyota, DHCS, SNN, Spectrum, Nursing

This program aims to address the disparities in autism identification and services, particularly among African American and LatinX students.

Key Points: 
  • This program aims to address the disparities in autism identification and services, particularly among African American and LatinX students.
  • Furthermore, SNN has received a $750,000 grant from the California Department of Health Services (DHCS) as part of the California Youth Behavioral Health (CYBH) initiative, dedicated to supporting mental health initiatives for youth.
  • This funding will bolster SNN's efforts to deliver culturally competent, anti-racist behavioral health services right in the communities that need them ymost.
  • Special Needs Network, Inc. is a nonprofit grassroots 501(c)(3) organization responding to the crisis of autism and other developmental disabilities in underserved communities.

Smith+Nephew and U.S. Army Institute of Surgical Research to engage in Master Cooperative Research and Development Agreement

Retrieved on: 
Wednesday, February 28, 2024
Commander, DOD, Life, Master, History, Patient, SNN, CRADA, COL, Development, Sports medicine, Research, Management

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announced they have entered into a Master Cooperative Research and Development Agreement (CRADA) with the U.S. Army Institute of Surgical Research (USAISR).

Key Points: 
  • Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announced they have entered into a Master Cooperative Research and Development Agreement (CRADA) with the U.S. Army Institute of Surgical Research (USAISR).
  • This marks the first time that the USAISR has entered into a master agreement of this nature with an industry-leading medical technology company.
  • The Master CRADA represents an enterprise-wide opportunity for Smith+Nephew across all business units - Advanced Wound Management, Orthopaedics and Sports Medicine - to enter into multiple collaborative research efforts.
  • “The pre-negotiated key terms and conditions of the Master CRADA provide the broad legal framework under which for multiple, future collaborative research efforts will be assigned.

Smith+Nephew announces commercial launch of its AETOS™ Shoulder System for anatomic and reverse shoulder replacement at AAOS 2024 Annual Meeting

Retrieved on: 
Tuesday, February 13, 2024
Software, Shoulder, ASC, Materialise NV, Partnership, 3D, Surgeon, Patient, SNN, Columbia University, Elective surgery, Sterilization, Sports medicine, Environment, American Academy, Medical device

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces full commercial availability of its AETOS Shoulder System in the US, along with 510(k) clearance for its use with ATLASPLAN◊ 3D Planning Software and Patient Specific Instrumentation for total shoulder arthroplasty.

Key Points: 
  • Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces full commercial availability of its AETOS Shoulder System in the US, along with 510(k) clearance for its use with ATLASPLAN◊ 3D Planning Software and Patient Specific Instrumentation for total shoulder arthroplasty.
  • “I’m thrilled with the stem fixation of the implant that the AETOS Shoulder System provides and believe it will be a noticeable, positive improvement for my patients,” said Dr. Matthew Ramsey, Shoulder and Elbow Specialist at Rothman Orthopaedics.
  • It is the latest addition to Smith+Nephew’s expanding Upper Extremity portfolio and complements our market-leading Sports Medicine shoulder repair solutions to enable biological healing.
  • To learn more please visit www.smith-nephew.com/aetos or visit the Smith+Nephew booth (#5469) at the American Academy of Orthopaedic Surgeons 2024 Annual Meeting from February 12-16 in San Francisco, CA.

Smith+Nephew to showcase leading, innovative AI-driven robotic-assisted solutions for personalized orthopaedic surgery at AAOS 2024 Annual Meeting  

Retrieved on: 
Monday, February 12, 2024
TKA, AI, MD, Patient satisfaction, Pain, Surgeon, 3D modeling, UKA, Risk, Deformity, THA, Associate, Patient, Duke University, SNN, Movement, AAOS, American Academy, Medical device

Smith+Nephew (LSE: SN, NYSE:SNN), the global medical technology company, announces it will provide a glimpse into the future at AAOS 2024.

Key Points: 
  • Smith+Nephew (LSE: SN, NYSE:SNN), the global medical technology company, announces it will provide a glimpse into the future at AAOS 2024.
  • Delivering solutions for differing patient types coupled with planning and execution tools is essential to personalizing surgery.
  • “Smith+Nephew’s technology platform is the only one in the market that allows for personalized planning using simulation and AI.
  • When introducing personalized options to manage specific pathologies, we see increased patient satisfaction and clinical outcomes.

Smith+Nephew unveils expanded Sports Medicine portfolio to enable biological healing at AAOS 2024 Annual Meeting

Retrieved on: 
Monday, February 12, 2024
Randomized controlled trial, MD, Pain, Hospital, Sale, Cartilage, Orthopedic surgery, Standard of care, Patient, SNN, Foot, Trauma, Environment, American Academy, Dentistry

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, announces the premiere of its newly acquired CARTIHEAL◊ AGILI-C◊ Cartilage Repair Implant alongside the REGENETEN◊ Bioinductive Implant at the AAOS Annual Meeting, demonstrating its leadership with products that enable biological healing for Sports Medicine.

Key Points: 
  • Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, announces the premiere of its newly acquired CARTIHEAL◊ AGILI-C◊ Cartilage Repair Implant alongside the REGENETEN◊ Bioinductive Implant at the AAOS Annual Meeting, demonstrating its leadership with products that enable biological healing for Sports Medicine.
  • It is indicated to treat a broad patient population, including traumatic, osteoarthritic and the approximately 700,0003 individuals who receive cartilage repair annually in the US.
  • The implant has demonstrated proven superiority with twice the pain reduction1 versus the current standard of care* and has the potential to transform cartilage repair outcomes.
  • “As a leader in Sports Medicine, we are committed to bringing emerging technologies that address unmet clinical needs to our customers and their patients,” said Scott Schaffner, President Sports Medicine, Smith+Nephew.

GIST Researchers Investigate Strange Transient Responses of Organic Electrochemical Transistors

Retrieved on: 
Tuesday, January 23, 2024
Engineering, Synapse, School, Research, SNNS, Professor, Nature Communications, Materials science, Neuron, OECT, SNN, Polymer, DTP

GWANGJU, South Korea, Jan. 23, 2024 /PRNewswire/ -- Organic mixed ionic–electronic conductors (OMIECs) are a highly sought-after class of materials for non-conventional applications, such as bioelectronics, neuromorphic computing, and bio-fuel cells, owing to their two-in-one electronic and ionic conduction properties. To ensure a much wider acceptance of these fascinating materials, there is a need to diversify their properties and develop techniques that allow application-specific tailoring of the features of OMIEC-based devices. A crucial aspect of this process is to develop strategies for evaluating the various properties of these materials. However, despite the increasing popularity of OMIECs, there is a severe lack of research on the molecular orientation-dependent transient behaviors of such conductors.

Key Points: 
  • However, despite the increasing popularity of OMIECs, there is a severe lack of research on the molecular orientation-dependent transient behaviors of such conductors.
  • In their recent breakthrough study published in Nature Communications on 28 November 2023, the team explored peculiar transient behaviors of OMIECs governed by variations in molecular orientation with the help of an organic electrochemical transistor (OECT).
  • We decided to investigate the correlation between backbone planarity-dependent molecular orientation and transient OECT characteristics."
  • To this end, the researchers first synthesized two new 1,4-dithienylphenylene (DTP)-based OMEICs, DTP-2T and DTP-P, with co-monomer units, 2,2'-bithiophene and phenylene, respectively.